利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

14 条记录 (耗时 0.011 秒)

    Fault tolerance based query execution
    11.
    发明授权
    Fault tolerance based query execution 有权
    基于容错的查询执行

    公开(公告)号：US09424150B2

    公开(公告)日：2016-08-23

    申请号：US13311596

    申请日：2011-12-06

    申请人： Zbigniew Jerzak ,  Thomas Heinze

    发明人： Zbigniew Jerzak ,  Thomas Heinze

    IPC分类号： G06F11/20 ,  G06F17/30

    CPC分类号： G06F11/2035 ,  G06F17/30477

    摘要： Various embodiments of systems and methods for a fault tolerance based query execution are described herein. Queries are received from users, the queries including operators. A multi-query optimization is performed on the operators included in the queries to obtain a query plan. A fault tolerance degree is determined for the operators included in the query plan. Based on the fault tolerance degree of the operators, nodes are assigned to the operators included in the query plan. The assigned nodes execute the operators included in the query plan to execute the queries. In one aspect, the nodes simultaneously execute the operators included in the query plan.

    摘要翻译： 本文描述了用于基于容错的查询执行的系统和方法的各种实施例。 来自用户的查询，包括运算符在内的查询。 对查询中包含的运算符执行多查询优化，以获取查询计划。 确定查询计划中包含的运营商的容错度。 根据运营商的容错度，将节点分配给查询计划中包含的运营商。 分配的节点执行查询计划中包含的运算符以执行查询。 在一个方面，节点同时执行查询计划中包括的运算符。

    Use of polysaccharide derivatives as anti-infective substances
    12.
    发明申请
    Use of polysaccharide derivatives as anti-infective substances 失效
    多糖衍生物作为抗感染物质的使用

    公开(公告)号：US20050054609A1

    公开(公告)日：2005-03-10

    申请号：US10500807

    申请日：2003-01-10

    申请人： Vera Haack ,  Thomas Heinze ,  Michaela Schmidtke ,  Ute Mollmann ,  Hans-Martin Dahse ,  Albert Hartl

    发明人： Vera Haack ,  Thomas Heinze ,  Michaela Schmidtke ,  Ute Mollmann ,  Hans-Martin Dahse ,  Albert Hartl

    IPC分类号： A61K8/72 ,  A01N33/12 ,  A01N63/00 ,  A61K8/73 ,  A61K31/715 ,  A61K31/716 ,  A61K31/717 ,  A61K31/718 ,  A61K31/719 ,  A61K31/721 ,  A61P31/04 ,  A61P31/12 ,  C08B31/12

    CPC分类号： A61K31/717 ,  A61K31/715 ,  A61K31/716 ,  A61K31/718 ,  A61K31/719 ,  A61K31/721

    摘要： The present invention relates to a method of treating infectious diseases, that involves: (a) providing an alpha-glycosidically linked starch polysaccharide derivative; and (b) inhibiting the growth of an infectious disease by administering a composition comprising the alpha-glycosidically linked starch polysaccharide derivative. The alpha-glycosidically linked starch polysaccharide derivative represented by the following general formula I, in which: the alpha-glycosidically linked starch polysaccharide derivative has a degree of quaternary ammonium group substitution of from 0.4 to 2.0; n is 2-4; R1 is selected from the group consisting of C1-4 alkyl, benzyl and benzyl substituted with a member selected from the group consisting of C1-3 alkyl, halogen, alcoxy, carbamoyl, alkoxycarbonyl, cyano, dialkylamino and hydrogen; R2 and R3 are each independently selected from the group consisting of C1-4 alkyl, benzyl and benzyl substituted with a member selected from the group consisting of C1-3 alkyl, halogen, alcoxy, carbamoyl, alkoxycarbonyl, cyano and dialkylamino; and X is an anion selected from the group consisting of halide, hydroxide, sulfate, hydrogen sulfate and carboxylate.

    摘要翻译： 本发明涉及一种治疗感染性疾病的方法，其涉及：（a）提供α-糖苷连接的淀粉多糖衍生物; 和（b）通过施用包含α-糖苷连接的淀粉多糖衍生物的组合物来抑制感染性疾病的生长。 由以下通式I表示的α-糖苷连接的淀粉多糖衍生物，其中：α-糖苷连接的淀粉多糖衍生物的季铵基取代度为0.4〜2.0; n为2-4; R1选自C1-4烷基，苄基和被选自C1-3烷基，卤素，烷氧基，氨基甲酰基，烷氧基羰基，氰基，二烷基氨基和氢的成员取代的苄基; R2和R3各自独立地选自C1-4烷基，苄基和被选自C1-3烷基，卤素，烷氧基，氨基甲酰基，烷氧基羰基，氰基和二烷基氨基的成员取代的苄基; X是选自卤化物，氢氧化物，硫酸盐，硫酸氢盐和羧酸盐的阴离子。